Treatment of posttraumatic stress disorder with nefazodone.

  title={Treatment of posttraumatic stress disorder with nefazodone.},
  author={Jonathan R. T. Davidson and Richard H. Weisler and Mary L Malik and Kathryn M. Connor},
  journal={International clinical psychopharmacology},
  volume={13 3},
Selective serotonin reuptake inhibitors are useful in the treatment of posttraumatic stress disorder (PTSD), but have a number of side-effects which limit their acceptability. A newer serotonergic compound, nefazodone, has a different side-effect profile, thus making it a potentially promising compound to study. Seventeen private practice patients with PTSD were treated with nefazodone up to 600 mg/day for a maximum total treatment period of 12 weeks. All subjects were civilians, and were… CONTINUE READING